ONS 2022 - 47th Annual Congress of Oncology Nursing Society
Apr 27 - May 01, 2022 | AnaheimCAUS
LARVOL is not affiliated with 47th Annual Congress of Oncology Nursing Society and all trademarks, logos, and brand names are property of their respective owners
Showing 16 abstracts linked to Trials
The phase 2 CAPTIVATE study: primary analysis of a fixed-duration cohort following first-line treatment with ibrutinib plus venetoclax for chronic lymphocytic leukemia/small lymphocytic lymphoma
Patient-reported outcomes in the GARNET trial in patients with advanced or recurrent mismatch repair deficient solid tumors treated with dostarlimab
Patient Identification for Chimeric Antigen Receptor T-Cell Therapy: Initial Insights From the CARTITUDE Program in Multiple Myeloma
Effects of Niraparib on Health-Related Quality of Life in the Final Analysis of the GALAHAD Study in Patients With Metastatic Castration-Resistant Prostate Cancer and Homologous Recombination Repair Gene Alterations
What Can Patients With Prostate Cancer Expect From Treatment With Apalutamide? Health-Related Quality of Life in Patients With Metastatic Castration-Sensitive Prostate Cancer in the Phase 3 TITAN Study
Combination of darolutamide with androgen-deprivation therapy and docetaxel increases survival for patients with metastatic hormone-sensitive prostate cancer in the phase 3 ARASENS study
A phase 2 study evaluating the addition of ublituximab and umbralisib (U2) to ibrutinib in patients with chronic lymphocytic leukemia (CLL): a minimal residual disease (MRD)-driven, time-limited approach
Onset, duration, and management of edema and effusion in patients treated with loncastuximab tesirine for R/R DLBCL: updated results from the LOTIS-2 clinical trial
Characterization and Management of Cutaneous Reactions in Patients with Relapsed or Refractory Diffuse Large B-cell Lymphoma Treated with Loncastuximab Tesirine in the LOTIS-2 Trial
Safety outcomes of olaparib as maintenance therapy following first-line platinum-based chemotherapy for patients with BRCA-mutated metastatic pancreatic cancer: results from the POLO study
Nursing experience with patients receiving sotorasib for KRAS G12C-mutated solid tumors: follow-up from the phase 1/2 CodeBreaK 100 study
The Role of the Allied Health Professional in Pharmaceutical Advisory Boards: Identifying Educational Needs to Improve Care Delivery
Practical Guide for Infusion-related Reaction (IRR) Management with Amivantamab for Exon 20 Insertion Mutation (Ex20ins) Non-small Cell Lung Cancer (NSCLC): A Nurse's View
Association Between Declines in Prostate-Specific Antigen and Patient-Reported Outcomes in Patients With Advanced Prostate Cancer Treated With Apalutamide in the SPARTAN and TITAN Studies
Clinical Strategies for Mitigation of Cytokine Release Syndrome and Neurotoxicity With Chimeric Antigen Receptor T Cell Therapy Ciltacabtagene Autoleucel in Multiple Myeloma